CERULEAN PHARMA INC's ticker is CERU and the CUSIP is 15708Q105. A total of 39 filers reported holding CERULEAN PHARMA INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,738,000 | -20.5% | 475,000 | 0.0% | 0.33% | +61.7% |
| Q2 2015 | $2,185,000 | -48.9% | 475,000 | 0.0% | 0.21% | -49.0% |
| Q1 2015 | $4,280,000 | +44.9% | 475,000 | 0.0% | 0.40% | +42.8% |
| Q4 2014 | $2,954,000 | +47.4% | 475,000 | 0.0% | 0.28% | +36.7% |
| Q3 2014 | $2,004,000 | -27.3% | 475,000 | 0.0% | 0.21% | -12.7% |
| Q2 2014 | $2,755,000 | – | 475,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,437,441 | $6,612,000 | 6.88% |
| Polaris Venture Management Co. V, L.L.C. | 3,287,529 | $15,123,000 | 6.74% |
| Cormorant Asset Management, LP | 551,354 | $2,536,000 | 0.34% |
| Deer VII & Co. Ltd. | 166,675 | $767,000 | 0.31% |
| Rock Springs Capital Management LP | 625,000 | $2,875,000 | 0.21% |
| WALL STREET ASSOCIATES | 475,000 | $2,185,000 | 0.21% |
| CLOUGH CAPITAL PARTNERS L P | 276,400 | $1,271,000 | 0.05% |
| TFS CAPITAL LLC | 103,648 | $477,000 | 0.05% |
| Granahan Investment Management | 332,225 | $1,528,000 | 0.04% |
| Northeast Financial Consultants Inc | 20,000 | $92,000 | 0.04% |